Chugai Pharmaceutical Co (4519N) Q2 2024 Earnings Report
MX:4519N Q2 2024 EPS Results
- Actual EPS
- MXN 8.05
- Consensus EPS
- MXN 6.40
- Beat/Miss
- Beat by +MXN 1.65
- One Year Ago EPS
- MXN 5.99
MX:4519N Q2 2024 Revenue Results
- Actual Revenue
- MXN 37.39B
- Expected Revenue
- MXN 32.62B
- Beat/Miss
- Beat by +MXN 4.78B
- YoY Revenue Growth
- +18.13%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/25/2024
- Time
- Before Open
- Conference Call
- Thursday, July 25, 2024
MX:4519N Upcoming Earnings
Chugai Pharmaceutical Co's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
MX:4519N Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4519N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 9.22- | 9.24 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 9.0711.00 | 9.03 | 21.81% (+1.97) | |
| Jul 24, 2026 | 2026 (Q2) | 8.968.14 | 6.85 | 18.95% (+1.30) | |
| Apr 24, 2026 | 2026 (Q1) | 7.868.30 | 6.99 | 18.68% (+1.31) | |
| Jan 29, 2026 | 2025 (Q4) | 8.769.24 | 6.59 | 40.24% (+2.65) | |
| Oct 24, 2025 | 2025 (Q3) | 8.829.03 | 7.88 | 14.67% (+1.16) | |
| Jul 24, 2025 | 2025 (Q2) | 8.776.85 | 8.05 | -14.93% (-1.20) | |
| Apr 24, 2025 | 2025 (Q1) | 6.036.99 | 5.35 | 30.67% (+1.64) | |
| Jan 30, 2025 | 2024 (Q4) | 6.986.59 | 6.56 | 0.37% (+0.02) | |
| Oct 25, 2024 | 2024 (Q3) | 7.157.88 | 5.58 | 41.15% (+2.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
